Pharma Mar | PHM - Current Assets


Pharma Mar reported EUR273.45M in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Akebia Therapeutics USD 243.48M 9.47M Mar/2026
Alaunos Therapeutics USD 970K 1.02M Mar/2026
Almirall EUR 713.98M 69K Dec/2025
Avita Medical AUD 35.49M 760K Dec/2025
Dianthus Therapeutics USD 1.12B 710.47M Mar/2026
Ionis Pharmaceuticals USD 2.94B 52M Mar/2026
IQVIA Holdings USD 6.22B 29M Mar/2026
Laboratorios Farma EUR 509.33M 128.63M Dec/2023
Moderna USD 5.77B 774M Mar/2026
Organon & Co USD 4.93B 580M Mar/2026
Pharma Mar EUR 273.45M 9.96M Mar/2026
Revvity USD 2.13B 111.43M Mar/2026
Tectonic Therapeutic USD 239.89M 17.47M Mar/2026
Viatris USD 10.92B 1.13B Mar/2026
Xeris Pharmaceuticals USD 251.68M 11.37M Mar/2026